Targeted readership

All recipients of our digital edition have personally requested their subscription, and all have been selected for their purchase influence for drug discovery products.

Only applicants who have had purchase influence for products or services over the last three years, have departmental buying authority, or are leading researchers, are eligible for a digital subscription.

Moving to a digital edition creates a platform for our long-term circulation growth, without the high costs for advertisers associated with print circulation. And for 2008, advertising rates for Drug Discovery Today are not being increased.